699810P

PHAD^™-504

Avanti Research^™ - A Croda Brand

• Sinônimo(s): Monophosphoryl Lipid A-504
• Fórmula empírica (Notação de Hill): C₉₄H₁₈₀ N₃O₂₂P
• Número CAS: 1332714-01-8
• Peso molecular: 1735.42
• Código UNSPSC: 12352211
• NACRES: NA.25

Propriedades

• Ensaio: >99% (HPLC)
• Formulário: powder
• embalagem: pkg of 1 × 1 mg (699810P-1mg); pkg of 1 × 5 mg (699810P-5mg)
• fabricante/nome comercial: Avanti Research^™ - A Croda Brand
• aplicação(ões): vaccine development
• Condições de expedição: dry ice
• temperatura de armazenamento: −20°C

Descrição

Descrição geral

PHAD^™-504 was designed as a synthetic structural analog of detoxified monophosphoryl lipid A (MPLA) derived from E. coli lipopolysaccharide (LPS). It is structurally similar to PHAD^™, differing only in the length of a single fatty acid chain. As expected, the activity of PHAD^™-504 is quite similar to that of PHAD^™, making the two products interchangeable as adjuvants in vaccine or immunotherapy formulations.

Embalagem

2 mL Amber Glass Crimp Cap Vial (699810P-1mg)

2 mL Amber Glass Crimp Cap Vial (699810P-5mg)

Outras notas

For R&D use only. Not for drug, household, or other uses.

Informações legais

Avanti Research is a trademark of Avanti Polar Lipids, LLC

PHAD is a trademark of Avanti Polar Lipids, LLC

Informações de segurança

• Código de classe de armazenamento: 11 - Combustible Solids
• Classe de risco de água (WGK): WGK 3
• Ponto de fulgor (°F): No data available
• Ponto de fulgor (°C): No data available